Clay Bernardin Thorp founded 5 companies, notably: PhaseBio Pharmaceuticals, Inc., Hatteras Venture Partners and Synthematix, Inc. Currently, he holds the position of Executive Chairman at PhaseBio Pharmaceuticals, Inc. (which he founded in 2002), Director at GeneCentric Therapeutics, Inc. and General Partner of Hatteras Venture Partners (which he founded in 2000). Mr. Thorp is also on the board of 5 other companies.
In his past career Clay Bernardin Thorp held the position of Advisor at Research Triangle Ventures LLC, Chairman & Chief Executive Officer of Synthematix, Inc. (he founded the company), President for Xanthon, Inc. (he founded the company) and Director-Corporate Development at Karo Bio USA, Inc. (he founded the company).
Mr. Thorp received a graduate degree from Harvard University and an undergraduate degree from The University of North Carolina at Charlotte.